NYSETEVA

Business

Teva stock gains on trial win, Q1 beat (NYSE:TEVA)

JHVEPhoto/iStock Editorial via Getty Images Teva Pharmaceutical (NYSE:TEVA) ADRs reached the highest level since 2019 after the generic drugmaker reported…

Read More »
Business

FDA approves Alvotech biosimilar of J&J top-selling drug Stelara (NYSE:TEVA)

Bet_Noire The FDA has approved Alvotech’s biosimilar of Johnson & Johnson’s (NYSE:JNJ) top-selling drug Stelara. The biosimilar, called Selarsdi, will…

Read More »
Back to top button